We are international
Donate
TEXT SIZE   


The International Myeloma Foundation Mourns the Passing of Board of Directors Member, Patient Champion, Michael S. Katz

This weekend the IMF lost a founding Board member who brought myeloma patient advocacy to the forefront. "Susie and I lost a dear and wonderful friend,” said IMF Chairman Dr. Brian Durie. “Mike Katz routinely inspired patients to take charge of their myeloma—to understand what is going on and get questions answered. He was a colleague and friend to patients and physicians alike. Mike, we will all miss you, we love you and will remember you always."

04.29.15

Los Angeles, CA - (April 29, 2015) - It is with great sadness that the International Myeloma Foundation (IMF) announces the death of Michael S. Katz, a longtime member of its Board of Directors.

"We are deeply saddened by the passing of Mike Katz," said Susie Novis, IMF President and Co-founder. "Mike was a dear friend and valued member of our Board, and he brought a wealth of experience, wisdom, and expertise to the IMF.”

“His leadership and friendship will be greatly missed,” said IMF Chairman Brian G.M. Durie. “On behalf of the IMF staff and the Board of Directors, I extend our deepest sympathies to his wife, Susie, and his three sons, Jonathan, Jeffrey and Jason."

Diagnosed with multiple myeloma in 1990, Mr. Katz worked as a volunteer for the IMF since 1993 and was very active in cancer advocacy. By establishing and exhaustively monitoring the ListServ for myeloma patients, he helped patients each day receive the correct information and to learn from others. While serving on the ECOG Myeloma Committee, he helped in the design of clinical trials which demonstrated that lower doses of Dexamethasone work as well (if not better than) higher doses and are much better tolerated than higher doses. This has been a huge advantage for many cancer patients, even beyond those with myeloma.

He chaired the National Cancer Institute's Directors Consumer Liaison Group and the Association of Cancer Online Resources, the Coalition of Cancer Cooperative Groups Patient Advisory Board and the Eastern Cooperative Oncology Group's Patient Representative Committee. He also served as a patient consultant for the U.S. Food and Drug Administration. He was a member of the American Society of Clinical Oncology's Research Policy Committee and a consumer representative for the Clinical Trials Transformation Initiatives.

Mr. Katz had a long and distinguished career with a global management consulting firm. His 30 years of consulting experience spanned manufacturing, consumer products, e-commerce, financial services, publishing, travel, direct marketing, credit card processing, communication, and other information industries. He received a bachelor’s degree in computer science and an MBA in management science, both from Columbia University.

If you wish to make a donation in memory of Mike Katz please click here.


 related articles